Literature DB >> 7588296

Apoptosis contributes to the involution of beta cell mass in the post partum rat pancreas.

L Scaglia1, F E Smith, S Bonner-Weir.   

Abstract

A significant reduction of beta cell mass has been described during the post partum period in the endocrine rat pancreas. We examined the mechanisms of this involution in Sprague Dawley rats by analyzing beta cell mass, beta cell replication, and beta cell size at end of pregnancy and 4 and 10 days after delivery. beta cell replication was significantly decreased at 4 days post partum but had returned back to nonpregnant levels by 10 days post partum. Similarly, beta cell size was significantly decreased at 4 and 10 days post partum as compared with the end of pregnancy, and at 10 days post partum was significantly decreased as compared with controls. At 4-6 days post partum, DNA fragmentation characteristic of apoptosis (programmed cell death) was detected in pancreatic islets, as assessed by in situ terminal deoxynucleotidyl transferase and nick translation assay. Only occasional cells were labeled with this assay in nonpregnant rats and at other time points after delivery. Condensed chromatin and apoptotic bodies, the morphological characteristics of apoptosis, were detected in beta cells of pancreatic islet at 3 and 4 days after delivery by electron microscopic analysis, confirming the occurrence of apoptosis in involuting islets. The expression of TRPM 2 and TGF beta 1, often enhanced in models of apoptosis, were studied during the post partum period by Northern blot analysis and immunohistochemistry. Levels of TRPM 2 gene and its protein, clusterin, were not different from controls; however, the TGF beta 1 gene and its protein expression were enhanced at 3 days post partum. Our study confirms the capability of beta cells to down-regulate their mass using the mechanisms of changes in rates of beta cell replication and of beta cell death, and changes in beta cell size to achieve homeostasis of the functional endocrine tissue.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7588296     DOI: 10.1210/endo.136.12.7588296

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  47 in total

1.  Beta cell adaptation in pregnancy: a major difference between humans and rodents?

Authors:  M Genevay; H Pontes; P Meda
Journal:  Diabetologia       Date:  2010-07-10       Impact factor: 10.122

2.  Discordance between GLP-1R gene and protein expression in mouse pancreatic islet cells.

Authors:  Sarah M Gray; Yurong Xin; Elizabeth C Ross; Bryanna M Chazotte; Megan E Capozzi; Kimberley El; Berit Svendsen; Peter Ravn; Kyle W Sloop; Jenny Tong; Jesper Gromada; Jonathan E Campbell; David A D'Alessio
Journal:  J Biol Chem       Date:  2020-06-18       Impact factor: 5.157

Review 3.  The role of interleukin-1 in the pathogenesis of IDDM.

Authors:  T Mandrup-Poulsen
Journal:  Diabetologia       Date:  1996-09       Impact factor: 10.122

4.  MicroRNAs contribute to compensatory β cell expansion during pregnancy and obesity.

Authors:  Cécile Jacovetti; Amar Abderrahmani; Géraldine Parnaud; Jean-Christophe Jonas; Marie-Line Peyot; Marion Cornu; Ross Laybutt; Emmanuelle Meugnier; Sophie Rome; Bernard Thorens; Marc Prentki; Domenico Bosco; Romano Regazzi
Journal:  J Clin Invest       Date:  2012-09-10       Impact factor: 14.808

5.  Glucose and fatty acids synergistically and reversibly promote beta cell proliferation in rats.

Authors:  Valentine S Moullé; Kevin Vivot; Caroline Tremblay; Bader Zarrouki; Julien Ghislain; Vincent Poitout
Journal:  Diabetologia       Date:  2017-01-11       Impact factor: 10.122

Review 6.  Expansion of beta-cell mass in response to pregnancy.

Authors:  Sebastian Rieck; Klaus H Kaestner
Journal:  Trends Endocrinol Metab       Date:  2009-12-16       Impact factor: 12.015

7.  Adaptive changes in pancreatic beta cell fractional area and beta cell turnover in human pregnancy.

Authors:  A E Butler; L Cao-Minh; R Galasso; R A Rizza; A Corradin; C Cobelli; P C Butler
Journal:  Diabetologia       Date:  2010-06-05       Impact factor: 10.122

8.  Pancreatic β-Cell Mass as a Pharmacologic Target in Diabetes.

Authors:  Stephen Hanley
Journal:  Mcgill J Med       Date:  2009-11-16

9.  Gestational diabetes mellitus resulting from impaired beta-cell compensation in the absence of FoxM1, a novel downstream effector of placental lactogen.

Authors:  Hongjie Zhang; Jia Zhang; Christine F Pope; Laura A Crawford; Rupangi C Vasavada; Shubhada M Jagasia; Maureen Gannon
Journal:  Diabetes       Date:  2009-10-15       Impact factor: 9.461

Review 10.  Slow and steady is the key to beta-cell replication.

Authors:  Kristen Brennand; Doug Melton
Journal:  J Cell Mol Med       Date:  2009-03       Impact factor: 5.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.